Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047904 · ClinicalTrials.gov registry record · NA
Anesthetizing the Tympanic Membrane in Healthy Volunteers
A NA study of Evaluate Performance and Reliability of Iontophoresis System, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT01047904 is a NA study of Evaluate Performance and Reliability of Iontophoresis System that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01047904, a NA study of Evaluate Performance and Reliability of Iontophoresis System, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate the performance and reliability of minor design changes to the Acclarent Iontophoresis System components for anesthetizing the tympanic membrane in healthy volunteers. Data collected from this study will enable the development of future applications and technology.
Conditions Studied
Interventions
- DEVICE Acclarent Iontophoresis System
Study Locations (1)
California
- - East Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-08 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01047904
The ClinicalTrials.gov registry entry for NCT01047904 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Evaluate Performance and Reliability of Iontophoresis System appearing as the primary indexed condition, and to 1 intervention - of which Acclarent Iontophoresis System is the first listed.
NCT01047904 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01047904 about?
NCT01047904 is a clinical study titled "Anesthetizing the Tympanic Membrane in Healthy Volunteers". The study will evaluate the performance and reliability of minor design changes to the Acclarent Iontophoresis System components for anesthetizing the tympanic membrane in healthy volunteers. Data collected from this study will enable the development of future applications and technology.
What is the current status of trial NCT01047904?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2009-08. Estimated completion is 2009-11.
What conditions does trial NCT01047904 study?
This clinical trial studies the following conditions: Evaluate Performance and Reliability of Iontophoresis System.
What interventions are being tested in trial NCT01047904?
The interventions under investigation include: Acclarent Iontophoresis System (DEVICE).
Who is sponsoring clinical trial NCT01047904?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01047904 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.